Your search history is turned on.
Date: August 20, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Securities Act NOTICE OF CHANGE IN CORPORATE STRUCTURE NATIONAL INSTRUMENT 51-102 Item 1 Names of the parties to the transaction Thallion Pharmaceuticals Inc. (Thallion), BELLUS Health Inc. (BELLUS) Item 2 Description of the transaction Pursuant to an acquisition agreement dated June 17, 2013, as amended, BELLUS ...
Date: August 16, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
REPORT PURSUANT TO REPORT PURSUANT TO NATIONAL INSTRUMENT 62-103 A. The name and address of the offeror: BELLUS Health Inc. 275 Armand-Frappier Blvd. Laval, Qubec H7V 4A7 B. The designation and number or principal amount of securities and the offeror's securityholding percentage in the class of securities of which the o...
Date: August 15, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Date: August 14, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - DOCS-#12708876-v1-Thallion_Dclaration_de_changement_important_-_Composante_au_comptant.doc ANNEXE 51-102A3 DCLARATION DE CHANGEMENT IMPORTANT Item 1 Dnomination et adresse de la socit Thallion Pharmaceutiques Inc. ( Thallion ) 1375, Route Transcanadienne Bureau 200 Dorval (Qubec) H9P 2W8 Item 2 Date du changement important Le 9 aot 2013. ...
Microsoft Word - DOCS-#12708873-v1-Thallion_Material_Change_Report_-_Cash_Component.doc FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Thallion Pharmaceuticals Inc. (Thallion) 1375 TransCanada Highway Suite 200 Dorval, Qubec H9P 2W8 Item 2 Date of Material Change August 9, 2013 Item 3 News Release A joint press release reporting the m...
Date: August 9, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - DOCS-#12695191-v3-Press_Release_-_Final_Effective_Net_Cash.doc THALLION PHARMACEUTICALS ANNOUNCES CASH COMPONENT OF $0.1889 PER SHARE Montral, August 9, 2013 Thallion Pharmaceuticals Inc. (Thallion) (TSX-V: TLN) and BELLUS Health Inc. (TSX: BLU) (BELLUS Health) announced today that in accordance with the acquisition agreement dated June 17, 201...
Microsoft Word - DOCS-#12697014-v1-Thallion_-_communiqu_de_presse.doc THALLION PHARMACEUTIQUES ANNONCE UNE COMPOSANTE AU COMPTANT DE 0,1889 $ PAR ACTION Montral, le 9 aot 2013 Thallion Pharmaceutiques Inc. (TSX-V : TLN) ( Thallion ) et BELLUS Sant inc. (TSX : BLU) ( BELLUS Sant ) ont annonc aujourdhui que, conformment la convention dacquisition date ...
Date: August 8, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - DOCS-#12690054-v1-Thallion_Dclaration_de_changment_important_-_Rsultats_du_vote__l_assemble_annuelle.doc ANNEXE 51-102A3 DCLARATION DE CHANGEMENT IMPORTANT Item 1 Dnomination et adresse de la socit Thallion Pharmaceutiques Inc. ( Thallion ) 1375, Route Transcanadienne Bureau 200 Dorval (Qubec) H9P 2W8 Item 2 Date du changement important ...
Microsoft Word - DOCS-#12690051-v1-Thallion_Material_Change_Report_-_Voting_results_at_annual_general_meeting.doc FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Thallion Pharmaceuticals Inc. (Thallion) 1375 TransCanada Highway Suite 200 Dorval, Qubec H9P 2W8 Item 2 Date of Material Change August 6, 2013 Item 3 News Release A joint pre...
Date: August 6, 2013 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - DOCS-#12646587-v2-Report_on_Voting_Results.doc THALLION PHARMACEUTICALS INC. REPORT ON VOTING RESULTS ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS HELD ON AUGUST 6, 2013 The annual and special meeting (the Meeting) of Thallion Pharmaceuticals Inc.s (Thallion) shareholders was held in Montral, Qubec on August 6, 2013 at 10:00 a.m. at the office...